Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, Wegovy is a once-weekly injectable using a user-friendly FlexTouch pen.

Everything is ready for you. Your dose of Wegovy is already set in the pen, so you don’t need to worry about giving yourself the correct amount. And the tiny Wegovy needle is already in place ...

The popular weight loss medications produced different results in patients who participated in a trial, and here’s what researchers found.

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.

New research shows that semaglutide, the compound in the weight-loss drug Wegovy, could treat an increasingly common liver disease.

Wegovy to be sold on Hims, Ro and LifeMD for reduced price The companies will sell the drug at a reduced price of $499 a month.

As semaglutide-based weight loss treatments such as Ozempic and Wegovy become more popular, new side effects are emerging – and one is hair loss ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight-loss drug Wegovy.

Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.